贫血,输血和高度子宫内膜癌的存活率:回顾性研究
Hannah H Foggin1, Pascal Lambert2,3, Lung Fung Tsang2
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Manitoba, Winnipeg, Manitoba, Canada hannah.foggin@gmail.com.
BMJ supportive & palliative care
|December 23, 2024
概括
高度子宫内膜癌化疗期间输血与较短的无复发存活期 (RFS) 有关. 贫血本身并没有影响本研究中的子宫内膜癌患者的生存结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 血液学 血液学 血液学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 高度子宫内膜癌 presents显著的治疗挑战.
- 术后,化疗,辐射相关性贫血和输血对生存的影响还不清楚.
研究的目的:
- 研究高度子宫内膜癌患者治疗期间贫血和输血以及整体存活率 (OS) 和无复发存活率 (RFS) 之间的关联.
主要方法:
- 对227名高度子宫内膜癌患者 (2010-2023) 的回顾性队列研究.
- 分析包括国际妇科和产科联合会 (FIGO) 3级子宫内膜异位,血清性,癌性肉瘤和其他高级组织学.
- 多变量考克斯回归模型评估了纳迪尔血红蛋白和输血状态与OS和RFS对比,并对混因素进行了调整.
主要成果:
- 在治疗期间,贫血很普遍 (64-86%),在0-10%的患者中出现严重的贫血.
- 9.7%的患者至少接受过一次输血.
- 术后和化疗期间的输血与较差的存活率有关,在化疗队列中显著影响了RFS (HR 3.22,p=0.04).
- 贫血和生存结果之间没有发现显著的关联.
结论:
- 这项研究表明,输血,特别是在化疗期间,可能会对高度子宫内膜癌的无复发生存产生负面影响.
- 需要进一步的大规模研究来验证这些发现,并为临床输血指南提供信息.
更多相关视频
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
11.2K
07:40Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery
Published on: May 16, 2018
7.4K
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:22Bone Marrow Sampling and Transplants
282
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
282
02:45Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K